Holds one active US DMF and one valid CEP for fluoxetine, filing since 1999. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 15 markets.
Holds one active US DMF and one valid CEP for fluoxetine, filing since 1999. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 15 markets.
Holds one active US DMF and one valid CEP for fluoxetine, filing since 1998. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and 2 valid CEPs for fluoxetine, filing since 2024. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF and 2 valid CEPs for fluoxetine, filing since 2012. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds one active US DMF and one valid CEP for fluoxetine, filing since 1994. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF and one valid CEP for fluoxetine, filing since 1995. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 3 active US DMFs and 2 valid CEPs for fluoxetine, filing since 1990. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for fluoxetine, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one valid CEP for fluoxetine, filing since 2025. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs and one valid CEP for fluoxetine, filing since 2005. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for fluoxetine, filing since 2025. Its 2023 FDA inspection closed as NAI.
Holds one active US DMF for fluoxetine, filing since 1996. Its 2023 FDA inspection closed as VAI.
Registered with DAV (Vietnam) for fluoxetine. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for fluoxetine. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for fluoxetine. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for fluoxetine. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for fluoxetine. Its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for fluoxetine and what filings they hold.
Chat with Fred, your AI analyst| Year | Median | Exporters |
|---|---|---|
| 2025 | $105.00 | 39 |
| 2024 | $110.44 | 41 |
| 2023 | $105.00 | 33 |
| 2022 | $114.65 | 26 |
US dollars per kilogram, customs export unit values.